Cargando…
SAT-242 Isolated Adrenocorticotropic Hormone Deficiency Secondary to the PD-1 Inhibitor Pembrolizumab
Background: Immune checkpoint inhibitors (ICI’s) are now indicated in the treatment of several solid tumors and have improved the prognosis of patients with advanced malignancy. The expanded use of ICI’s has led to the rise of otherwise rare autoimmune sequelae. The overall incidence of ICI-induced...
Autores principales: | Mathew, Justin, Mathias, Priyanka, Bloomgarden, Noah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208957/ http://dx.doi.org/10.1210/jendso/bvaa046.979 |
Ejemplares similares
-
SAT-454 Isolated ACTH Deficiency Due to Pembrolizumab
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019) -
MON-243 Atypical Presentation of Isolated Adrenocorticotropic Hormone Deficiency and Sheehan’s Syndrome
por: Lugo López, Zahira Marie, et al.
Publicado: (2020) -
SAT-240 Hypothalamic Lipoma and Growth Hormone Deficiency
por: Rochtus, Anne Maria, et al.
Publicado: (2020) -
ODP303 Cushing's Syndrome Due to Ectopic Adrenocorticotropic Hormone-Secreting Metastatic Neuroendocrine Tumor
por: Cipriani, Allison, et al.
Publicado: (2022) -
SUN-291 Presence of Aberrant Adrenocorticotropic Hormone Precursors in Two Cases of McCune- Albright Syndrome
por: Yamagata, Satoshi, et al.
Publicado: (2020)